Investors

Insider Transactions

Date Name Sorted Descending Title Type Shares Traded Price Range
Aug 22, 2013 ryan arthur f Director Option Execute 30,000 18.61 - 57.11
Aug 22, 2013 ryan arthur f Director Disposition (Non Open Market) 4,042 236.64
May 31, 2013 ryan arthur f Director Sell 2,500 249.45 - 249.58
May 23, 2013 ryan arthur f Director Disposition (Non Open Market) 3,000 n/a
Nov 1, 2012 ryan arthur f Director Sell 10,000 145.57
Aug 10, 2012 ryan arthur f Director Sell 10,000 136.15
May 10, 2012 ryan arthur f Director Disposition (Non Open Market) 7,000 n/a
Jan 12, 2012 ryan arthur f Director Sell 25,500 78.86 - 79.09
Sep 14, 2011 ryan arthur f Director Option Execute 115,000 9.17 - 24.41
Sep 14, 2011 ryan arthur f Director Disposition (Non Open Market) 32,145 64.85
Jun 14, 2010 ryan arthur f Director Buy 10,000 26.98
Sep 19, 2013 roberts william Officer Automatic Sell 4,000 n/a
Sep 18, 2013 roberts william Officer Option Execute 15,000 16.80
Sep 18, 2013 roberts william Officer Automatic Sell 15,000 304.00
Jun 13, 2013 roberts william Officer Disposition (Non Open Market) 4,000 n/a
Jun 13, 2013 roberts william Officer Acquisition (Non Open Market) 4,000 n/a
Nov 30, 2012 roberts william Officer Sell 11,500 177.43 - 186.00
Nov 27, 2012 roberts william Officer Disposition (Non Open Market) 11,500 n/a
Nov 27, 2012 roberts william Officer Acquisition (Non Open Market) 11,500 n/a
Nov 5, 2012 roberts william Officer Acquisition (Non Open Market) 26,000 n/a
Showing 401-420 of 897 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)